dicloxacillin.
All isolates of Streptococcus pyogenes were inhibited by 0.39 ,"g/ml. cocci, representing 3 genera and compared to the activity of 5 other antibiotics using a microdiluter4) Isolates of Diplococcus pneumoniae and Streptococcus pyogenes were inoculated into Tryptose-phosphate broth containing 2 % human blood. The isolates were incubated for 18 hours at 37°C. A 50ml aliquot of a 10-3 dilution of this broth was added to wells containing 50ml volumes of the antibiotics, resulting in a total of 100 l in each well. The antibiotics used were clindamycin (The Upjohn Co., Kalamazoo, Michigan), dicloxacillin (BeechamMassengill, Inc., Clifton, New Jersey), erythromycin (Abbott Laboratories, North Chicago, Illinois), minocycline (Lederle Laboratories, Pearl River, New York), cephalothin (Eli Lilly and Co., Indianapolis, Indiana) and kitasamycin tartrate (Ayerst Laboratories, New York, New York). They were dissolved in MUELLER-HINTON broth and two-fold serial dilutions were prepared, ranging in concentration from 25 pg/ml to 0.0251tg/ml. The minimum inhibitory concentration (MIC) was determined after incubation at 37°C for 18 hours. All studies were performed in triplicate. Disk sensitivity testing was performed according to the method of BAUER et all).
Seventeen isolates of Dipl. pneumoniae, 47 isolates of Str. pyogenes, and 150 isolates of Staphylococcus aureus were tested. One hundred isolates of S. aureus were resistant to penicillin G at a concentration of 50pg/ml. The remaining 50 isolates were inhibited by less than 0.1 pg/ml penicillin G. Most of the organisms were isolated from cancer patients hospitalized at this institution between August 1971 and January 1973.
Results Tables 1 and 2 .25 ,reg/ml of kitasamycin. The remaining 1 % were resistant to 25 pg/ml. Erythromycin was the most active of the 6 antibiotics against Dipl. pneumoniae (Fig. 2) . All of the isolates were inhibited by 0.05 pg/ml. Although the other 5 antibiotics were comparable in activity, dicloxacillin was the least active. All of the 17 isolates of Dipl. pneumoniae were inhibited by 1.56 pg/ml of all 5 antibiotics.
Erythromycin was the most active antibiotic against Str. pyogenes (Fig. 3) . All of the isolates were inhibited by 0.2 pg/ml. Cephalothin and kitasamycin were the least active antibiotics against Str. pyogenes. At a concentration of 0.1 pg/ml, erythromycin inhibited 95 % of isolates, clindamycin inhibited 94 %, dicloxacillin inhibited 92 %, cephalothin inhibited 61% and kitasamycin inhibited 17 % Cephalothin was the most active antibiotic against the 50 isolates of S. aureus sensitive to penicillin G (Fig. 4) . All of the isolates were inhibited by 0.2 pg/ml. Dicloxacillin and minocycline also inhibited all of the isolates, at a concentration of 0.78 pg/ml. One isolate was resistant to 25 hg/ml of the other 3 antibiotics. Kitasamycin was substantially less active than the other antibiotics. Clindamycin was the most active antibiotic against the 100 isolates of S. aureus resistant to penicillin G (Fig. 5) . All of the isolates were inhibited by 0.1 ug/ml. Minocycline and dicloxacillin also inhibited all of the isolates at higher concentrations. One isolate was resistant to kitasamycin and cephalothin and 13 isolates were resistant to erythromycin. Kitasamycin was the least active antibiotic against most of the isolates.
Discussion
Our results are comparable to those obtained by other investigators who tested kitasamycin against isolates of Dipl. pneumoniae and Str. pyogenes5 8) . In our study there was no difference in the activity of kitasamycin against staphylococci, regardless of their sensitivity to penicillin G. Only 1 % of isolates of S. aureus which were resistant to penicillin G were resistant to kitasamvcin. All of these isolates were sensitive to clindamycin, minocycline and dicloxacillin, but 13% were resistant to erythromycin. Kitasamycin has activity against the vast majority of clinical isolates of S. aureus, Str. pyogenes and Dipl. pneumoniae, but in vitro studies do not suggest that it has any advantages over currently available antibiotics, although it would be expected to be effective in clinical situations in which erythromycin is indicated.
